Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / COMMON STOCK-FO
-
Total 13F shares
-
205,310,351
-
Share change
-
-510,610
-
Total reported value
-
$21,118,883,631
-
Put/Call ratio
-
150%
-
Price per share
-
$102.85
-
Number of holders
-
508
-
Value change
-
-$146,065,915
-
Number of buys
-
201
-
Number of sells
-
292
Institutional Holders of HORIZON THERAPEUTICS PLC - COMMON STOCK-FO (HZNP) as of Q2 2023
As of 30 Jun 2023,
HORIZON THERAPEUTICS PLC - COMMON STOCK-FO (HZNP) was held by
508 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
205,310,351 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., Pentwater Capital Management LP, Avoro Capital Advisors LLC, FARALLON CAPITAL MANAGEMENT LLC, NORGES BANK, JPMORGAN CHASE & CO, STATE STREET CORP, CITADEL ADVISORS LLC, and UBS OCONNOR LLC.
This page lists
508
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.